Saitoh T - Search Results

1

Sub-lethal doses of chemotherapeutic agents induce senescence in T cells and upregulation of PD-1 expression.

Kasamatsu T, Awata-Shiraiwa M, Ishihara R, Murakami Y, Masuda Y, Gotoh N, Oda T, Yokohama A, Matsumura I, Handa H, Tsukamoto N, Murakami H, Saitoh T. Kasamatsu T, et al. Among authors: saitoh t. Clin Exp Med. 2023 Oct;23(6):2695-2703. doi: 10.1007/s10238-023-01034-z. Epub 2023 Mar 13. Clin Exp Med. 2023. PMID: 36913034

2

PDCD1 and PDCD1LG1 polymorphisms affect the susceptibility to multiple myeloma.

Kasamatsu T, Awata M, Ishihara R, Murakami Y, Gotoh N, Matsumoto M, Sawamura M, Yokohama A, Handa H, Tsukamoto N, Saitoh T, Murakami H. Kasamatsu T, et al. Among authors: saitoh t. Clin Exp Med. 2020 Feb;20(1):51-62. doi: 10.1007/s10238-019-00585-4. Epub 2019 Oct 16. Clin Exp Med. 2020. PMID: 31620907

3

IDO2 rs10109853 polymorphism affects the susceptibility to multiple myeloma.

Kasamatsu T, Hashimoto N, Sakaya N, Awata-Shiraiwa M, Ishihara R, Murakami Y, Masuda Y, Gotoh N, Nagai K, Oda T, Yokohama A, Saitoh T, Handa H, Tsukamoto N, Hayashi K, Murakami H. Kasamatsu T, et al. Among authors: saitoh t. Clin Exp Med. 2021 May;21(2):323-329. doi: 10.1007/s10238-020-00681-w. Epub 2021 Mar 12. Clin Exp Med. 2021. PMID: 33709342

4

[Diagnosis and management guideline for multiple myeloma].

Murakami H, Handa H, Saitoh T. Murakami H, et al. Among authors: saitoh t. Nihon Rinsho. 2007 Dec;65(12):2167-76. Nihon Rinsho. 2007. PMID: 18069257 Review. Japanese.

5

[Diagnosis and prognostic factors in patients with multiple myeloma].

Murakami H, Yokohama A, Saitoh T, Tsukamoto N, Handa H. Murakami H, et al. Among authors: saitoh t. Nihon Rinsho. 2012 Apr;70 Suppl 2:584-8. Nihon Rinsho. 2012. PMID: 23134019 Japanese. No abstract available.

6

The cytokine polymorphisms affecting Th1/Th2 increase the susceptibility to, and severity of, chronic ITP.

Takahashi N, Saitoh T, Gotoh N, Nitta Y, Alkebsi L, Kasamatsu T, Minato Y, Yokohama A, Tsukamoto N, Handa H, Murakami H. Takahashi N, et al. Among authors: saitoh t. BMC Immunol. 2017 May 16;18(1):26. doi: 10.1186/s12865-017-0210-3. BMC Immunol. 2017. PMID: 28511637 Free PMC article.

7

Short-term administration of recombinant human erythropoietin decreases B cell number in human peripheral blood.

Nagashima T, Yokohama A, Nagai K, Kasamatsu T, Gotoh N, Iriuchishima H, Sekigami T, Saitoh T, Handa H, Tsukamoto N, Murakami H. Nagashima T, et al. Among authors: saitoh t. Transfus Apher Sci. 2018 Apr;57(2):208-214. doi: 10.1016/j.transci.2018.01.009. Epub 2018 Feb 2. Transfus Apher Sci. 2018. PMID: 29439918

8

DNA Damage Response in Multiple Myeloma: The Role of the Tumor Microenvironment.

Saitoh T, Oda T. Saitoh T, et al. Cancers (Basel). 2021 Jan 28;13(3):504. doi: 10.3390/cancers13030504. Cancers (Basel). 2021. PMID: 33525741 Free PMC article. Review.

9

DNA-double strand breaks enhance the expression of major histocompatibility complex class II through the ATM-NF-κΒ-IRF1-CIITA pathway.

Oda T, Nakamura R, Kasamatsu T, Gotoh N, Okuda K, Saitoh T, Handa H, Murakami H, Yamashita T. Oda T, et al. Among authors: saitoh t. Cancer Gene Ther. 2022 Feb;29(2):225-240. doi: 10.1038/s41417-021-00302-y. Epub 2021 Feb 22. Cancer Gene Ther. 2022. PMID: 33619341

10

Clinical significance of human endogenous retrovirus K (HERV-K) in multiple myeloma progression.

Masuda Y, Ishihara R, Murakami Y, Watanabe S, Asao Y, Gotoh N, Kasamatsu T, Takei H, Kobayashi N, Saitoh T, Murakami H, Handa H. Masuda Y, et al. Among authors: saitoh t. Int J Hematol. 2023 Apr;117(4):563-577. doi: 10.1007/s12185-022-03513-7. Epub 2022 Dec 16. Int J Hematol. 2023. PMID: 36522589

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,100 results

Search Page